Cross-resistance in the 2',2'-difluorodeoxycytidine (gemcitabine)-resistant human ovarian cancer cell line AG6000 to standard and investigational drugs

Author: Bergman A.M.   Giaccone G.   van Moorsel C.J.A.   Mauritz R.   Noordhuis P.   Pinedo H.M.   Peters G.J.  

Publisher: Elsevier

ISSN: 0959-8049

Source: European Journal of Cancer, Vol.36, Iss.15, 2000-10, pp. : 1974-1983

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content